Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.78 USD | -2.33% | -5.39% | -20.83% |
May. 07 | Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M | MT |
May. 07 | Transcript : Veracyte, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 406M | Sales 2025 * | 448M | Capitalization | 1.67B |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | 9M | EV / Sales 2024 * | 3.55 x |
Net cash position 2024 * | 226M | Net cash position 2025 * | 291M | EV / Sales 2025 * | 3.06 x |
P/E ratio 2024 * |
-422
x | P/E ratio 2025 * |
192
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.15% |
Latest transcript on Veracyte, Inc.
1 day | -2.33% | ||
1 week | -5.39% | ||
Current month | +11.29% | ||
1 month | +11.98% | ||
3 months | -11.25% | ||
6 months | -13.50% | ||
Current year | -20.83% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 21-05-31 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 21-07-18 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 08-01-31 |
Robert Epstein
CHM | Chairman | 69 | 15-01-11 |
Karin Eastham
BRD | Director/Board Member | 74 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 21.78 | -2.33% | 688,902 |
24-05-20 | 22.3 | -2.53% | 562,899 |
24-05-17 | 22.88 | -2.22% | 628,696 |
24-05-16 | 23.4 | -0.64% | 659,169 |
24-05-15 | 23.55 | +2.30% | 737,880 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.83% | 1.7B | |
-27.66% | 9.41B | |
+26.94% | 2.9B | |
-15.73% | 2.16B | |
+67.18% | 1.51B | |
+26.08% | 814M | |
-4.15% | 760M | |
-28.78% | 529M | |
+3.98% | 312M | |
-24.19% | 183M |
- Stock Market
- Equities
- VCYT Stock